Latest news
Otsuka’s Voyxact raises the bar in IgA nephropathy - biocentury.combiocentury.com · Fri, 07 Aug 2026 22:14:00 GMTPrice to sales forward of Otsuka Holdings Co., Ltd. – SWB:OS1 - TradingViewTradingView · Wed, 05 Aug 2026 11:21:21 GMTOtsuka Unveils Unprecedented Phase 3 VISIONARY Two-Year eGFR Results Demonstrating VOYXACT® (sibeprenlimab-szsi) Stabilizes Kidney Function Decline to Baseline Physiologic Rate, Fundamentally Altering Disease Progression in IgA Nephropathy - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 21:00:00 GMTOtsuka Holdings Co., Ltd. (OTSKF) stock price, news, quote and history - Yahoo Finance UKYahoo Finance UK · Mon, 03 Aug 2026 11:13:47 GMTAPAC Healthcare Weekly (August 2) – CSPC, Hengrui, Otsuka, Nippon Shinyaku, PharmaEssnetia, Cipla - SmartkarmaSmartkarma · Sun, 02 Aug 2026 01:43:09 GMTOtsuka Holdings Co., Ltd. 2026 Q2 - Results - Earnings Call Presentation (OTCMKTS:OTSKY) 2026-08-01 - Seeking AlphaSeeking Alpha · Sat, 01 Aug 2026 04:32:22 GMTOtsuka Holdings Raises FY2026 Sales and EPS Guidance - scanx.tradescanx.trade · Fri, 31 Jul 2026 07:00:00 GMTOtsuka Holdings Q2 Results: EPS rises 20.69% YoY to $0.70 - scanx.tradescanx.trade · Fri, 31 Jul 2026 07:00:00 GMT